Furthermore, clinical studies have reported that the levels of drebrin A are significantly reduced in the brain of patients with major cognitive impairment, such as Alzheimer’s disease [392] and schizophrenia [381]. The gene discussed is DBN1; the disease is early-onset autosomal dominant Alzheimer disease.